Among apoptosis pathway components, BCL2A1, one of the hypoxia-responsive genes of the BCL2 family, was found to be significantly induced by 5.5-fold in hypoxia-treated gynecological cancer cells (Figure 1A and Figure S1). This evidence concerns the gene BCL2 and female reproductive organ cancer.